Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Fulda

Showing results (101-110 of 287) with videos related to

Pageof 29
Sort By:
Oncotarget|October 17, 2015
JNJ-26481585 primes rhabdomyosarcoma cells for chemotherapeutics by engaging the mitochondrial pathway of apoptosisUlrike Heinicke, Johanna Kupka, Simone Fulda
Anti-Cancer Agents in Medicinal Chemistry|October 1, 2010
Therapeutic exploitation of apoptosis and autophagy for glioblastomaDonat Kögel, Simone Fulda, Michel Mittelbronn
Nature Reviews. Drug Discovery|May 15, 2010
Targeting mitochondria for cancer therapySimone Fulda, Lorenzo Galluzzi, Guido Kroemer
Leukemia & Lymphoma|December 17, 2009
More (on) prognostic factors in chronic lymphocytic leukemiaThorsten Zenz, Simone Fulda, Stephan Stilgenbauer
Cancer Letters|April 29, 2015
Smac mimetic and oleanolic acid synergize to induce cell death in human hepatocellular carcinoma cellsJuliane Liese, Behnaz Ahangarian Abhari, Simone Fulda
Oncogene|September 14, 2004
Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cellsSimone Fulda, Irmela Jeremias, Klaus-Michael Debatin
Seminars in Cancer Biology|March 26, 2003
Apoptosis in hematological disordersKlaus Michael Debatin, Karsten Stahnke, Simone Fulda
Oncogene|April 12, 2002
Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpressionSimone Fulda, Eric Meyer, Klaus-Michael Debatin
Cancer Letters|June 9, 2016
Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blockedSabine Hannes, Behnaz Ahangarian Abhari, Simone Fulda
Cancer Letters|May 21, 2013
Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcomaMonika Katharina Guenther, Ulrike Graab, Simone Fulda
Pageof 29

Showing results (101-110 of 287) with videos related to

Sort By:
Pageof 29
Oncotarget|October 17, 2015
JNJ-26481585 primes rhabdomyosarcoma cells for chemotherapeutics by engaging the mitochondrial pathway of apoptosisUlrike Heinicke, Johanna Kupka, Simone Fulda
Anti-Cancer Agents in Medicinal Chemistry|October 1, 2010
Therapeutic exploitation of apoptosis and autophagy for glioblastomaDonat Kögel, Simone Fulda, Michel Mittelbronn
Nature Reviews. Drug Discovery|May 15, 2010
Targeting mitochondria for cancer therapySimone Fulda, Lorenzo Galluzzi, Guido Kroemer
Leukemia & Lymphoma|December 17, 2009
More (on) prognostic factors in chronic lymphocytic leukemiaThorsten Zenz, Simone Fulda, Stephan Stilgenbauer
Cancer Letters|April 29, 2015
Smac mimetic and oleanolic acid synergize to induce cell death in human hepatocellular carcinoma cellsJuliane Liese, Behnaz Ahangarian Abhari, Simone Fulda
Oncogene|September 14, 2004
Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cellsSimone Fulda, Irmela Jeremias, Klaus-Michael Debatin
Seminars in Cancer Biology|March 26, 2003
Apoptosis in hematological disordersKlaus Michael Debatin, Karsten Stahnke, Simone Fulda
Oncogene|April 12, 2002
Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpressionSimone Fulda, Eric Meyer, Klaus-Michael Debatin
Cancer Letters|June 9, 2016
Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blockedSabine Hannes, Behnaz Ahangarian Abhari, Simone Fulda
Cancer Letters|May 21, 2013
Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcomaMonika Katharina Guenther, Ulrike Graab, Simone Fulda
Pageof 29